<p class="MsoNormal"><span lang="EN-IN">Lenalidomide has become a game-changer in the treatment of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. This immunomodulatory drug works by stimulating the immune system to target and destroy cancerous cells, while also inhibiting the growth of Tumor cells. Lenalidomide, produced by trusted lenalidomide manufacturers in India, not only improves survival rates but also reduces the risk of disease progression in multiple myeloma patients.</span>

<p class="MsoNormal"><span lang="EN-IN">Its effectiveness is further enhanced when used in combination with other therapies, such as dexamethasone or bortezomib, providing a comprehensive treatment approach. Lenalidomide ability to manage the disease long-term, with relatively manageable side effects, makes it a preferred option for many patients.</span>



<p class="MsoNormal"><span lang="EN-IN">The global demand for Lenalidomide is met by various manufacturers, ensuring that multiple myeloma patients worldwide have access to effective treatment options.</span>